US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurocrine Biosciences

126.55

-0.7600-0.60%

Post-market: 126.550.00000.00%17:01 EDT

Volume:1.58M

Turnover:199.40M

Market Cap:12.52B

PE:42.79

High:128.38

Open:127.88

Low:125.53

Close:127.31

Loading ...

Overview Company News Filings

BRIEF-Neurocrine Biosciences Q1 Adjusted EPS USD 0.7 Vs. IBES Estimate USD 0.54

Neurocrine Biosciences Q1 EPS USD 0.08

THOMSON REUTERS

Neurocrine Biosciences Reports First Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance

THOMSON REUTERS

Neurocrine Biosciences Reports First Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance

Neurocrine Biosciences Announces New Survey Revealing Need for Routine Screening and Earlier Diagnosis for People Living with Tardive Dyskinesia

Neurocrine Biosciences Launches Phase 3 Trial for Schizophrenia Drug NBI-1117568

MT Newswires Live

Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia

Neurocrine Biosciences, Inc. (NBIX): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential

Neurocrine Biosciences Starting Phase 3 Trial of Prospective Schizophrenia Medication

MT Newswires Live

BRIEF-Neurocrine Biosciences Initiates Phase 3 Registrational Program For NBI-1117568

Neurocrine Biosciences Initiates Phase 3 Registrational Program for Nbi-1117568 as Potential Treatment for Adults With Schizophrenia

THOMSON REUTERS

Neurocrine Biosciences Inc - Phase 3 Study to Enroll Approximately 280 Schizophrenia Patients

THOMSON REUTERS

Neurocrine Biosciences Initiates Phase 3 Registrational Program for NBI-1117568 as Potential Treatment for Adults with Schizophrenia

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Valneva (VALN) and BridgeBio Pharma (BBIO)

Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?

Neurocrine Is Maintained at Buy by Canaccord Genuity

Neurocrine Biosciences Publishes Analysis Showing Long-Term Efficacy and a Consistent Safety Profile of INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia in The Journal of Clinical Psychiatry

Neurocrine Is Maintained at Outperform by Evercore ISI Group

Stifel Nicolaus Reaffirms Their Buy Rating on Neurocrine (NBIX)

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NBIX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","market":"US","secType":"STK","nameCN":"Neurocrine Biosciences","latestPrice":126.55,"timestamp":1750449600000,"preClose":127.31,"halted":0,"volume":1575263,"hourTrading":{"tag":"盘后","latestPrice":126.55,"preClose":126.55,"latestTime":"17:01 EDT","volume":325318,"amount":41169012.2605,"timestamp":1750453316266},"delay":0,"floatShares":97783376,"shares":98965820,"eps":2.957321,"marketStatus":"Market Closed","change":-0.76,"latestTime":"06-20 16:00:00 EDT","open":127.88,"high":128.38,"low":125.53,"amount":199397215.86101,"amplitude":0.022386,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.957321,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":832824000000,"exchange":"NASDAQ","adjPreClose":127.31,"preHourTrading":{"tag":"盘前","latestPrice":127.2,"preClose":127.31,"latestTime":"09:27 EDT","volume":2092,"amount":268123.87868,"timestamp":1750426060600},"postHourTrading":{"tag":"盘后","latestPrice":126.55,"preClose":126.55,"latestTime":"17:01 EDT","volume":325318,"amount":41169012.2605,"timestamp":1750453316266},"volumeRatio":2.065439,"impliedVol":0.3091,"impliedVolPercentile":0.176},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","floatShares":97783376,"roa":"8.75%","roe":"12.43%","lyrEps":3.399402,"volumeRatio":2.065439,"shares":98965820,"dividePrice":0,"high":128.38,"amplitude":0.022386,"preClose":127.31,"low":125.53,"week52Low":84.23,"pbRate":"4.94","psRate":"5.19","week52High":157.9799,"institutionHeld":0.9508,"latestPrice":126.55,"eps":2.957321,"divideRate":0,"volume":1575263,"delay":0,"ttmEps":2.957321,"open":127.88,"prevYearClose":136.5,"prevWeekClose":124.39,"prevMonthClose":123.02,"prevQuarterClose":110.6,"fiveDayClose":125.01,"twentyDayClose":120.56,"sixtyDayClose":116.18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBIX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533550552","title":"BRIEF-Neurocrine Biosciences Q1 Adjusted EPS USD 0.7 Vs. IBES Estimate USD 0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2533550552","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533550552?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:01","pubTimestamp":1746475310,"startTime":"0","endTime":"0","summary":"BRIEF-Neurocrine Biosciences Q1 Adjusted EPS USD 0.7 Vs. IBES Estimate USD 0.54\n\n\nMay 05 (Reuters) - Neurocrine Biosciences Q1 adjusted net income USD 71.5 million vs. IBES estimate USD 63.6 million.\n\nQ1 EPS USD 0.08\nQ1 product sales USD 545.2 million\nQ1 net income USD 7.9 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLXEB4EB5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIX"],"gpt_icon":0},{"id":"2533572575","title":"Neurocrine Biosciences Q1 EPS USD 0.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2533572575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533572575?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:01","pubTimestamp":1746475265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLXEB4EB5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","LU2065170008.USD","LU0320765992.SGD","LU2065171402.SGD","LU0109394709.USD","LU2324357040.USD","LU2065171311.SGD","LU2065169927.USD","BK4139","NBIX","LU0889565916.HKD"],"gpt_icon":0},{"id":"2533557798","title":"Neurocrine Biosciences Reports First Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2533557798","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533557798?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:01","pubTimestamp":1746475265,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUABXWM9C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065169927.USD","LU2065170008.USD","LU0109394709.USD","LU2065171402.SGD","BK4139","NBIX","LU2065171311.SGD","LU0823416689.USD","LU2324357040.USD","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2533191568","title":"Neurocrine Biosciences Reports First Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2533191568","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533191568?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:01","pubTimestamp":1746475260,"startTime":"0","endTime":"0","summary":"INGREZZA  First-Quarter 2025 Net Product Sales of $545 Million and Reaffirms 2025 Net Product Sales Guidance of $2.5 - $2.6 Billion. CRENESSITYTM  First-Quarter 2025 Net Product Sales of $14.5 Million with 413 Total Patient Enrollment Start Forms. Initiated Phase 3 Registrational Programs for Osavampator in Major Depressive Disorder and NBI-'568 in Schizophrenia to Position for Next Phase of Growth. SAN DIEGO, May 5, 2025 /PRNewswire/ --Neurocrine Biosciences, Inc.  today announced its financial results for the first quarter ended March31, 2025, and reaffirms its 2025 financial guidance.\"We delivered a record number of new patient starts for INGREZZA, which is especially impressive given the typically challenging first quarter. This strong performance gives us good momentum heading into the rest of the year. We are reaffirming 2025 INGREZZA net sales guidance of $2.5 to $2.6 billion,\" said Kyle W. Gano, Ph.D., Chief Executive Officer of Neurocrine Biosciences. \"For CRENESSITY, we are e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurocrine-biosciences-reports-first-quarter-200100999.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-reports-first-quarter-200100999.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NBIX","BK4139","LU0109394709.USD","BK4566","LU0823416689.USD","LU2065169927.USD","LU2065170008.USD","LU2324357040.USD","BK4585","LU2065171402.SGD","BK4207","LU0889565916.HKD","LU2065171311.SGD","TD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2533581885","title":"Neurocrine Biosciences Announces New Survey Revealing Need for Routine Screening and Earlier Diagnosis for People Living with Tardive Dyskinesia","url":"https://stock-news.laohu8.com/highlight/detail?id=2533581885","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533581885?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:30","pubTimestamp":1746448200,"startTime":"0","endTime":"0","summary":"-- Majority of individuals polled reported tardive dyskinesia negatively impacts their day-to-day ability to function, including individuals living with mild or moderate uncontrolled movements1. SAN DIEGO, May 5, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc.  today announced the release of findings from a new survey conducted by The Harris Poll highlighting the profound negative impact of tardive dyskinesia on patients and reinforcing the need for routine screening, earlier diagnosis and treatment. The findings revealed that 80% of people living with tardive dyskinesia surveyed wished they had been screened for the condition earlier, and 86% wished their provider had discussed available treatment options for their uncontrolled movements sooner.1*. \"These findings highlight the significant daily challenges faced by people living with tardive dyskinesia,\" said Eiry W. Roberts, M.D., Chief Medical Officer, Neurocrine Biosciences. \"This underscores the importance of regular screening t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurocrine-biosciences-announces-survey-revealing-123000559.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-announces-survey-revealing-123000559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065171311.SGD","NBIX","LU2065170008.USD","TD","LU2065171402.SGD","LU0109394709.USD","LU2324357040.USD","BK4566","BK4139","LU0889565916.HKD","LU0320765992.SGD","LU2065169927.USD","BK4207","BK4585","LU0823416689.USD"],"gpt_icon":0},{"id":"2532596168","title":"Neurocrine Biosciences Launches Phase 3 Trial for Schizophrenia Drug NBI-1117568","url":"https://stock-news.laohu8.com/highlight/detail?id=2532596168","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532596168?lang=en_us&edition=fundamental","pubTime":"2025-05-02 09:48","pubTimestamp":1746150527,"startTime":"0","endTime":"0","summary":"Nxera Pharma Co  partner Neurocrine Biosciences has initiated a Phase 3 trial for NBI-1117568, an oral muscarinic M4 receptor agonist, for treating schizophrenia, according to a Thursday filing on the Tokyo Stock Exchange.The trial follows positive Phase 2 results reported in August 2024, showing a significant reduction in symptoms.The global, placebo-controlled trial will enroll around 280 patients with acute schizophrenia symptoms. The primary endpoint is the reduction of PANSS score, with secondary endpoints focusing on clinical severity.No milestone payment is due at trial start, but a $15 million payment will be triggered when the first patient is dosed.Price : $934.00, Change: $+18, Percent Change: +1.97%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU0823416689.USD","LU2065171311.SGD","LU2065169927.USD","LU2065171402.SGD","BK4139","NBI","LU2324357040.USD","NBIX","LU0320765992.SGD","JPY","LU2065170008.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2532742015","title":"Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2532742015","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532742015?lang=en_us&edition=fundamental","pubTime":"2025-05-01 07:35","pubTimestamp":1746056100,"startTime":"0","endTime":"0","summary":"NBI-1117568 is an oral, muscarinic M4 selective receptor agonist discovered by Nxera advancing through clinical development under a multi-program collaboration with Neurocrine. For more information, please read Neurocrine’s announcement . About NBI-1117568 NBI-1117568 is the first and only investigational oral muscarinic M4 selective orthosteric agonist in clinical development for the treatment of schizophrenia. There are five muscarinic acetylcholine receptors involved in neurotransmission. Muscarinic receptors are central to brain function and validated as drug targets in psychosis and cognitive disorders. As an M4 selective orthosteric agonist, NBI-1117568 offers the potential for a novel mechanism with an improved safety profile without the n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nxera-pharma-partner-neurocrine-biosciences-233500668.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SOLTF","NBIX","BK4007","BK4233","BK4528","LU0823416689.USD","LU2065170008.USD","LU0320765992.SGD","LU2065171402.SGD","LU0109394709.USD","LU2324357040.USD","LU2065171311.SGD","NBI","LU2065169927.USD","BK4139","UK","BK4205","LU0889565916.HKD"],"gpt_icon":0},{"id":"2532506844","title":"Neurocrine Biosciences, Inc. (NBIX): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2532506844","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532506844?lang=en_us&edition=fundamental","pubTime":"2025-04-30 23:43","pubTimestamp":1746027793,"startTime":"0","endTime":"0","summary":"We recently published a list of Billionaire Cliff Asness’ 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Neurocrine Biosciences, Inc.  stands against other billionaire Cliff Asness’ stock picks with huge upside potential.Cliff Asness, the founder, managing principal, and chief investment officer ofAQR Capital Management, is a well-known figure in the world of finance. Starting with a $10 million commitment from a small group of investors in 1995, Asness was able to boost the Goldman Sachs Global Alpha Fund’s assets to more than $100 million in just a handful of months. Cliff Asness’ investment strategies, which focus on value and momentum, have delivered exceptional returns for AQR, setting him apart from his fellow hedge fund managers. As a testament, the fund has produced positive returns over the last three years, with its greatest year in 2022, when it returned 43.5%.A sovereign wealth fund for the U.S., which President Trump has al","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-inc-nbix-among-154313748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0128525689.USD","USAW.SI","LU2065171402.SGD","LU0889566641.SGD","BK4594","LU0823416689.USD","TSYW.SI","LU0889565916.HKD","LU0072461881.USD","MNQmain","QID","BK4585","LU1571399168.USD","SG9999001440.SGD","LU0211327993.USD","PSQ","LU0320765992.SGD","BK4139","TQQQ","LU1267930490.SGD","LU0310799852.SGD","NVIW.SI","LU0154236417.USD","LU1880398554.USD","LU2324357040.USD","BK4588","LU0211328371.USD","LU0109394709.USD","SQQQ","NQmain","LU0162691827.USD","LU2065169927.USD",".IXIC","LU0052756011.USD","LU0792757196.USD","LU1267930227.SGD","LU0006061336.USD","LU1267930813.SGD","LU2065170008.USD","USJW.SI","CAH","BK4601","LU1880398471.USD","NBIX","LU0310800965.SGD","LU2065171311.SGD","BK4175","QLD"],"gpt_icon":1},{"id":"2531057681","title":"Neurocrine Biosciences Starting Phase 3 Trial of Prospective Schizophrenia Medication","url":"https://stock-news.laohu8.com/highlight/detail?id=2531057681","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531057681?lang=en_us&edition=fundamental","pubTime":"2025-04-30 23:06","pubTimestamp":1746025619,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences  has begun registering prospective patients for a phase 3 trial to evaluate the efficacy, safety and tolerability of its NBI-1117568 drug candidate to treat adults with a primary diagnosis of schizophrenia, the company said on Wednesday morning.The new, doubled-blinded study is expected to enroll around 280 patients who are experiencing an acute exacerbation or relapse of schizophrenia symptoms and will receive a once-daily 20 milligram dose of the investigational oral muscarinic M4 selective orthosteric agonist.The upcoming trial will have a primary endpoint of the reduction from baseline as measured by the Positive and Negative Syndrome Scale and a key secondary endpoint of improvement on the Clinical Global Impression of Severity scale.During phase 2 testing, top-line data reported last August showed clinically meaningful and statistically significant reduction from baseline on the PANSS total score after six weeks compared with patients treated with a placebo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","LU0109394709.USD","LU2065170008.USD","LU0889565916.HKD","NBIX","BK4139","LU2065171402.SGD","LU2065171311.SGD","LU0823416689.USD","LU2065169927.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2531144039","title":"BRIEF-Neurocrine Biosciences Initiates Phase 3 Registrational Program For NBI-1117568","url":"https://stock-news.laohu8.com/highlight/detail?id=2531144039","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531144039?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:04","pubTimestamp":1746014662,"startTime":"0","endTime":"0","summary":"BRIEF-Neurocrine Biosciences Initiates Phase 3 Registrational Program For NBI-1117568 April 30 (Reuters) - Neurocrine Biosciences Inc NBIX.O:NEUROCRINE BIOSCIENCES INITIATES PHASE 3 REGISTRATIONAL PRO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA51JBYV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIX","LU2065170008.USD","LU2065171311.SGD","LU2324357040.USD","LU0320765992.SGD","LU0823416689.USD","BK4139","LU0889565916.HKD","LU2065169927.USD","LU2065171402.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2531633039","title":"Neurocrine Biosciences Initiates Phase 3 Registrational Program for Nbi-1117568 as Potential Treatment for Adults With Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2531633039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531633039?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:00","pubTimestamp":1746014409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA51JBYV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","LU2065171402.SGD","LU2324357040.USD","LU0889565916.HKD","NBIX","LU2065170008.USD","LU0320765992.SGD","LU0823416689.USD","LU2065169927.USD","LU2065171311.SGD","BK4139"],"gpt_icon":0},{"id":"2531039650","title":"Neurocrine Biosciences Inc - Phase 3 Study to Enroll Approximately 280 Schizophrenia Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2531039650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531039650?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:00","pubTimestamp":1746014409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA51JBYV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","LU0320765992.SGD","LU2065171311.SGD","LU0823416689.USD","LU2065170008.USD","LU2324357040.USD","BK4139","LU0109394709.USD","LU2065169927.USD","LU0889565916.HKD","NBIX"],"gpt_icon":0},{"id":"2531039430","title":"Neurocrine Biosciences Initiates Phase 3 Registrational Program for NBI-1117568 as Potential Treatment for Adults with Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2531039430","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531039430?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:00","pubTimestamp":1746014400,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April 30, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc.  today announced the initiation of a Phase 3 registrational program to evaluate the efficacy, safety and tolerability of NBI-1117568, the company's investigational oral muscarinic M4 selective orthosteric agonist, as a potential treatment for schizophrenia. Positive top-line data for the Phase 2 clinical study in adults with schizophrenia were reported in August 2024.\"There is a significant need for new and innovative medicines to treat schizophrenia, a disorder that impacts millions of people and their families,\" said Eiry W. Roberts, M.D., Chief Medical Officer, Neurocrine Biosciences. \"With positive Phase 2 data in hand, we're excited to advance this investigational novel compound that works directly and selectively at the muscarinic M4 receptor.\". About Neurocrine Biosciences' Muscarinic PortfolioIn addition to NBI-1117568,Neurocrinehas a broad portfolio of assets in clinical development that selectively target ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurocrine-biosciences-initiates-phase-3-120000091.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-initiates-phase-3-120000091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU2324357040.USD","LU2065171311.SGD","NBI","LU2065169927.USD","LU2065171402.SGD","NBIX","LU0823416689.USD","LU0109394709.USD","LU2065170008.USD","BK4139"],"gpt_icon":0},{"id":"2531787536","title":"Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Valneva (VALN) and BridgeBio Pharma (BBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2531787536","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531787536?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:50","pubTimestamp":1745927413,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neurocrine (NBIX – Research Report), Valneva (VALN –...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurocrine-nbix-valneva-valn-and-bridgebio-pharma-bbio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurocrine-nbix-valneva-valn-and-bridgebio-pharma-bbio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU0320765992.SGD","LU2324357040.USD","BK4539","HCSG","BK4585","LU0889565916.HKD","BK4139","LU2065169927.USD","BK4137","LU2065171402.SGD","LU2065171311.SGD","BK4505","BK4588","VALN","LU2065170008.USD","LU0823416689.USD","BBIO","NBIX"],"gpt_icon":0},{"id":"2530009233","title":"Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?","url":"https://stock-news.laohu8.com/highlight/detail?id=2530009233","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530009233?lang=en_us&edition=fundamental","pubTime":"2025-04-28 22:00","pubTimestamp":1745848835,"startTime":"0","endTime":"0","summary":"Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when Neurocrine Biosciences  reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 5. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This biopharmaceutical company is expected to post quarterly earnings of $0.42 per share in its upcoming report, which represents no change from the year-ago qua","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-nbix-q1-earnings-140035070.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["UTHR","NBIX"],"gpt_icon":0},{"id":"2530403109","title":"Neurocrine Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2530403109","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530403109?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:59","pubTimestamp":1745841540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NBIX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 28, 2025 07:59 ET (11:59 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIX"],"gpt_icon":0},{"id":"2530699827","title":"Neurocrine Biosciences Publishes Analysis Showing Long-Term Efficacy and a Consistent Safety Profile of INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia in The Journal of Clinical Psychiatry","url":"https://stock-news.laohu8.com/highlight/detail?id=2530699827","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530699827?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:05","pubTimestamp":1745525100,"startTime":"0","endTime":"0","summary":"Post-hoc analysis of higher risk older adults showed substantial and sustained improvements in tardive dyskinesia symptoms with no new treatment-emergent adverse events of clinical concern. SAN DIEGO, April 24, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc.  today announced publication of a post-hoc analysis from two 48-week studies, the KINECT 3 extension and KINECT 4, demonstrating the long-term safety profile and robust efficacy of INGREZZA  capsules in adults aged 65 years and older with tardive dyskinesia  inThe Journal of Clinical Psychiatry. This represents the first and only published peer-reviewed analysis of a vesicular monoamine transporter 2 inhibitor for the treatment ofTD in older adults , a group at higher risk for TD and associated consequences.\"This analysis, the first and only of its kind in a peer-reviewed publication, addresses an important gap in research on this potentially vulnerable population,\" said Eiry W. Roberts, M.D., Chief Medical Officer, Neurocrine Bi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/neurocrine-biosciences-publishes-analysis-showing-200500549.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-biosciences-publishes-analysis-showing-200500549.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1989772840.SGD","LU0820562030.AUD","BK4534","HD","LU0320765992.SGD","BK4139","LU0823416689.USD","BK4585","LU0868494617.USD","LU1674673428.USD","LU0820561818.USD","LU0109394709.USD","BK4533","LU2756315318.SGD","TD","BK4504","SG9999001440.SGD","LU0889565916.HKD","LU1035775433.USD","LU1162221912.USD","BK4550","BK4083","LU0823411888.USD","LU1914381329.SGD","LU1778281490.HKD","LU2065171311.SGD","NMS","BK4581","LU1093756168.USD","LU1551013342.USD","NBIX","BK4207","BK4567","IE00BSNM7G36.USD","LU0354030438.USD","LU1069344957.HKD","BK4588","LU1929549753.HKD","LU1551013425.SGD","LU1989772923.USD","IE00BZ1G4Q59.USD","LU2324357040.USD","LU0354030511.USD","LU2065169927.USD","LU0234572021.USD","LU0943347566.SGD","LU2065170008.USD","IE00B1XK9C88.USD","LU1093756325.SGD","IE00BWXC8680.SGD"],"gpt_icon":0},{"id":"2529938042","title":"Neurocrine Is Maintained at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2529938042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529938042?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:21","pubTimestamp":1745500860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NBIX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 24, 2025 09:21 ET (13:21 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIX"],"gpt_icon":0},{"id":"2529262639","title":"Stifel Nicolaus Reaffirms Their Buy Rating on Neurocrine (NBIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529262639","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529262639?lang=en_us&edition=fundamental","pubTime":"2025-04-23 23:15","pubTimestamp":1745421348,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Neurocrine (NBIX – Research Report) today and set a price target of $166.00. The co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-neurocrine-nbix?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-neurocrine-nbix?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","NBIX"],"gpt_icon":0},{"id":"2529047945","title":"Exploring 3 High Growth Tech Stocks In The US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2529047945","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529047945?lang=en_us&edition=fundamental","pubTime":"2025-04-23 19:38","pubTimestamp":1745408300,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has experienced a 1.7% drop, but it has shown resilience with a 3.6% rise over the past year and an anticipated annual earnings growth of 13%. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for innovation and scalability in alignment with these positive long-term market trends.Top 10 High Growth Tech Companies In The United States. Click here to see the full list of 233 stocks from our US High Growth Tech and AI Stocks screener.Unlock comprehensive insights into our analysis of Bitdeer Technologies Group stock in this health report.Examine Bitdeer Technologies Group's past performance report to understand how it has performed in the past.Overview: Neurocrine Biosciences, Inc. focuses on discovering, developing, and marketing pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders globally, with a market cap of approximately $10.04 billion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-3-high-growth-tech-113820363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4595","ONC","NBIX","BTDR","BK4023","BK4600"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":196,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-05","symbol":"NBIX","fiscalQuarterEnding":"2025/03","expectedEps":0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"post","actualEps":0.08},{"market":"US","date":"2025-02-06","symbol":"NBIX","fiscalQuarterEnding":"2024/12","expectedEps":1.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"post","actualEps":1},{"market":"US","date":"2024-10-30","symbol":"NBIX","fiscalQuarterEnding":"2024/09","expectedEps":1.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"pre","actualEps":1.24},{"market":"US","date":"2024-08-01","symbol":"NBIX","fiscalQuarterEnding":"2024/06","expectedEps":1.15,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":0.63},{"market":"US","date":"2024-05-01","symbol":"NBIX","fiscalQuarterEnding":"2024/03","expectedEps":1.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714536000000,"reportTimeType":"pre","actualEps":0.42}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3462,"buy":0.5,"hold":0.1538,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":26,"updateTime":1746590400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBIX","date":"2025-06-18","current":40.414819,"percent":0.404549,"low":15.452095,"twenty":26.680493,"median":54.092022,"eighty":113.591967,"high":905.986584,"avg":103.769077,"sd":175.082104,"marketCap":12358851601},"quantilePoints":[{"date":"2020-06-26","current":68.588653,"twenty":-85.975998,"median":-50.521811,"eighty":264.609771,"marketCap":12105897173},{"date":"2020-07-02","current":65.963174,"twenty":-85.955472,"median":-50.372722,"eighty":264.609771,"marketCap":11642500219},{"date":"2020-07-10","current":68.236133,"twenty":-85.785889,"median":-50.132555,"eighty":264.609771,"marketCap":12043677542},{"date":"2020-07-17","current":68.672836,"twenty":-85.623376,"median":-49.948259,"eighty":264.609771,"marketCap":12120755592},{"date":"2020-07-24","current":65.873729,"twenty":-85.227519,"median":-49.703126,"eighty":264.609771,"marketCap":11626713149},{"date":"2020-07-31","current":63.327173,"twenty":-84.91567,"median":-49.467785,"eighty":264.609771,"marketCap":11177245963},{"date":"2020-08-07","current":52.414884,"twenty":-84.564123,"median":-49.335886,"eighty":264.609771,"marketCap":10734568315},{"date":"2020-08-14","current":52.087035,"twenty":-84.490725,"median":-49.027477,"eighty":264.609771,"marketCap":10667424808},{"date":"2020-08-21","current":51.504192,"twenty":-84.414156,"median":-48.599484,"eighty":264.609771,"marketCap":10548058571},{"date":"2020-08-28","current":52.055161,"twenty":-84.383616,"median":-48.427294,"eighty":264.609771,"marketCap":10660896967},{"date":"2020-09-04","current":50.115387,"twenty":-84.164648,"median":-48.297263,"eighty":264.609771,"marketCap":10263631212},{"date":"2020-09-11","current":45.71219,"twenty":-84.021232,"median":-48.111608,"eighty":264.609771,"marketCap":9361856600},{"date":"2020-09-18","current":46.285926,"twenty":-83.682042,"median":-47.881304,"eighty":264.609771,"marketCap":9479357738},{"date":"2020-09-25","current":44.48731,"twenty":-83.463658,"median":-47.607315,"eighty":264.609771,"marketCap":9111000994},{"date":"2020-10-02","current":43.075737,"twenty":-83.463658,"median":-47.501461,"eighty":264.609771,"marketCap":8821910891},{"date":"2020-10-09","current":47.547235,"twenty":-83.463658,"median":-47.244256,"eighty":264.609771,"marketCap":9737673734},{"date":"2020-10-16","current":46.677524,"twenty":-83.039861,"median":-46.798492,"eighty":264.609771,"marketCap":9559556928},{"date":"2020-10-23","current":45.083813,"twenty":-82.052389,"median":-46.535456,"eighty":264.609771,"marketCap":9233164876},{"date":"2020-10-30","current":44.928995,"twenty":-81.511414,"median":-46.178337,"eighty":264.609771,"marketCap":9201458220},{"date":"2020-11-06","current":43.868039,"twenty":-80.971335,"median":-45.857748,"eighty":264.609771,"marketCap":8984174368},{"date":"2020-11-13","current":92.00871,"twenty":-80.52487,"median":-45.670701,"eighty":264.609771,"marketCap":8593613492},{"date":"2020-11-20","current":89.02778,"twenty":-79.90576,"median":-45.354214,"eighty":264.609771,"marketCap":8315194617},{"date":"2020-11-27","current":95.589827,"twenty":-79.6114,"median":-44.789283,"eighty":264.609771,"marketCap":8928089860},{"date":"2020-12-04","current":96.56013,"twenty":-79.346554,"median":-44.606027,"eighty":264.609771,"marketCap":9018716139},{"date":"2020-12-11","current":90.238157,"twenty":-78.964538,"median":-44.452865,"eighty":264.609771,"marketCap":8428243892},{"date":"2020-12-18","current":101.461659,"twenty":-78.437014,"median":-44.344704,"eighty":264.609771,"marketCap":9476518988},{"date":"2020-12-24","current":97.700486,"twenty":-78.222461,"median":-44.198304,"eighty":264.609771,"marketCap":9125225373},{"date":"2020-12-31","current":95.879918,"twenty":-77.80504,"median":-44.134512,"eighty":264.609771,"marketCap":8955184315},{"date":"2021-01-08","current":112.10498,"twenty":-77.629297,"median":-44.073414,"eighty":264.609771,"marketCap":10470605176},{"date":"2021-01-15","current":107.723613,"twenty":-77.54001,"median":-43.670322,"eighty":264.609771,"marketCap":10061385486},{"date":"2021-01-22","current":116.946491,"twenty":-77.430808,"median":-43.464999,"eighty":264.609771,"marketCap":10922802277},{"date":"2021-01-29","current":109.784256,"twenty":-77.197706,"median":-42.778855,"eighty":264.609771,"marketCap":10253849541},{"date":"2021-02-05","current":26.640957,"twenty":-77.197706,"median":-42.474008,"eighty":264.609771,"marketCap":10850861829},{"date":"2021-02-12","current":26.317137,"twenty":-77.197706,"median":-42.17745,"eighty":264.609771,"marketCap":10718969894},{"date":"2021-02-19","current":26.118778,"twenty":-77.197706,"median":-42.062964,"eighty":264.609771,"marketCap":10638178359},{"date":"2021-02-26","current":25.258455,"twenty":-77.197706,"median":-41.584197,"eighty":264.609771,"marketCap":10287768563},{"date":"2021-03-05","current":21.503477,"twenty":-77.235212,"median":-41.157807,"eighty":264.839255,"marketCap":8758366023},{"date":"2021-03-12","current":22.386865,"twenty":-77.235212,"median":-40.711654,"eighty":264.839255,"marketCap":9118170183},{"date":"2021-03-19","current":21.27052,"twenty":-77.235212,"median":-40.499511,"eighty":264.839255,"marketCap":8663482941},{"date":"2021-03-26","current":22.802035,"twenty":-77.197706,"median":-40.21778,"eighty":264.609771,"marketCap":9287268744},{"date":"2021-04-01","current":22.645193,"twenty":-77.197706,"median":-40.046982,"eighty":264.609771,"marketCap":9223387066},{"date":"2021-04-09","current":21.531155,"twenty":-77.111586,"median":-39.534588,"eighty":264.839255,"marketCap":8769639260},{"date":"2021-04-16","current":22.416552,"twenty":-76.721508,"median":-39.218794,"eighty":264.839255,"marketCap":9130261672},{"date":"2021-04-23","current":22.451368,"twenty":-75.974265,"median":-38.968034,"eighty":264.839255,"marketCap":9144442033},{"date":"2021-04-30","current":21.931456,"twenty":-74.817508,"median":-38.74439,"eighty":264.839255,"marketCap":8932681978},{"date":"2021-05-07","current":21.41161,"twenty":-74.315581,"median":-38.555072,"eighty":264.839255,"marketCap":8607467020},{"date":"2021-05-14","current":22.248882,"twenty":-73.863213,"median":-38.496002,"eighty":264.839255,"marketCap":8944050748},{"date":"2021-05-21","current":22.571091,"twenty":-73.160572,"median":-38.28134,"eighty":264.839255,"marketCap":9073578756},{"date":"2021-05-28","current":22.629889,"twenty":-72.277254,"median":-38.009435,"eighty":264.839255,"marketCap":9097215254},{"date":"2021-06-04","current":22.199493,"twenty":-71.999066,"median":-37.801929,"eighty":264.839255,"marketCap":8924196090},{"date":"2021-06-11","current":23.19199,"twenty":-71.242038,"median":-37.604814,"eighty":264.839255,"marketCap":9323180172},{"date":"2021-06-18","current":23.641202,"twenty":-70.605258,"median":-37.435625,"eighty":264.839255,"marketCap":9503763015},{"date":"2021-06-25","current":23.587108,"twenty":-70.169335,"median":-37.262869,"eighty":264.839255,"marketCap":9482017437},{"date":"2021-07-02","current":23.19199,"twenty":-69.420808,"median":-37.098736,"eighty":264.839255,"marketCap":9323180172},{"date":"2021-07-09","current":23.29077,"twenty":-68.775295,"median":-36.410287,"eighty":264.839255,"marketCap":9362889488},{"date":"2021-07-16","current":22.340606,"twenty":-67.912494,"median":-36.154968,"eighty":264.839255,"marketCap":8980923685},{"date":"2021-07-23","current":23.170823,"twenty":-65.471686,"median":-35.92931,"eighty":264.839255,"marketCap":9314671033},{"date":"2021-07-30","current":21.92197,"twenty":-64.037727,"median":-35.475637,"eighty":264.839255,"marketCap":8812631821},{"date":"2021-08-06","current":23.245079,"twenty":-62.98807,"median":20.197999,"eighty":264.839255,"marketCap":8477480466},{"date":"2021-08-13","current":23.128296,"twenty":-60.309524,"median":20.991434,"eighty":264.839255,"marketCap":8434889574},{"date":"2021-08-20","current":23.81083,"twenty":-59.363602,"median":21.378926,"eighty":264.839255,"marketCap":8683809677},{"date":"2021-08-27","current":24.711359,"twenty":-58.891511,"median":21.503477,"eighty":264.839255,"marketCap":9012232778},{"date":"2021-09-03","current":24.880046,"twenty":-57.788755,"median":21.578659,"eighty":264.839255,"marketCap":9073752956},{"date":"2021-09-10","current":25.105828,"twenty":-57.393419,"median":21.731847,"eighty":264.839255,"marketCap":9156095347},{"date":"2021-09-17","current":25.043543,"twenty":-57.122936,"median":21.874823,"eighty":264.839255,"marketCap":9133380205},{"date":"2021-09-24","current":24.65167,"twenty":-56.515676,"median":21.983228,"eighty":264.839255,"marketCap":8990464100},{"date":"2021-10-01","current":26.330755,"twenty":-56.073302,"median":22.061434,"eighty":264.839255,"marketCap":9602826483},{"date":"2021-10-08","current":27.010694,"twenty":-54.272284,"median":22.130844,"eighty":264.839255,"marketCap":9850800122},{"date":"2021-10-15","current":27.130073,"twenty":-53.483205,"median":22.199493,"eighty":264.839255,"marketCap":9894337478},{"date":"2021-10-22","current":26.870554,"twenty":-53.14751,"median":22.365311,"eighty":264.839255,"marketCap":9799691051},{"date":"2021-10-29","current":27.355854,"twenty":-53.059611,"median":22.416552,"eighty":264.839255,"marketCap":9976679870},{"date":"2021-11-05","current":19.879776,"twenty":-52.91578,"median":22.430689,"eighty":264.839255,"marketCap":8842524454},{"date":"2021-11-12","current":18.76859,"twenty":-52.59512,"median":22.430689,"eighty":264.839255,"marketCap":8348268984},{"date":"2021-11-19","current":18.346297,"twenty":-52.419753,"median":22.430689,"eighty":264.839255,"marketCap":8160432931},{"date":"2021-11-26","current":18.551045,"twenty":-52.090504,"median":22.430689,"eighty":264.839255,"marketCap":8251504957},{"date":"2021-12-03","current":16.994105,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7558978098},{"date":"2021-12-10","current":16.987707,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7556132097},{"date":"2021-12-17","current":18.476398,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8218301614},{"date":"2021-12-23","current":18.147947,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8072206907},{"date":"2021-12-31","current":18.16501,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8079796242},{"date":"2022-01-07","current":16.064207,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7145359316},{"date":"2022-01-14","current":16.712577,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7433754063},{"date":"2022-01-21","current":16.017286,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7124488644},{"date":"2022-01-28","current":16.364931,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7279121353},{"date":"2022-02-04","current":17.305493,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7697483470},{"date":"2022-02-11","current":90.557458,"twenty":-51.955042,"median":22.431842,"eighty":264.609771,"marketCap":8113948252},{"date":"2022-02-18","current":90.693144,"twenty":-51.955042,"median":22.522526,"eighty":264.609771,"marketCap":8126105713},{"date":"2022-02-25","current":94.45608,"twenty":-51.955042,"median":22.586516,"eighty":264.609771,"marketCap":8463264811},{"date":"2022-03-04","current":93.743886,"twenty":-51.955042,"median":22.661461,"eighty":264.609771,"marketCap":8399452213},{"date":"2022-03-11","current":94.91316,"twenty":-51.955042,"median":22.80063,"eighty":264.609771,"marketCap":8504219165},{"date":"2022-03-18","current":98.99499,"twenty":-51.908672,"median":22.903884,"eighty":264.609771,"marketCap":8869951067},{"date":"2022-03-25","current":99.622146,"twenty":-51.908672,"median":23.045631,"eighty":264.609771,"marketCap":8926144250},{"date":"2022-04-01","current":101.588652,"twenty":-51.908672,"median":23.1378,"eighty":264.609771,"marketCap":9102343214},{"date":"2022-04-08","current":106.372046,"twenty":-51.908672,"median":23.19199,"eighty":264.609771,"marketCap":9530935287},{"date":"2022-04-14","current":105.521665,"twenty":-51.879725,"median":23.286066,"eighty":264.609771,"marketCap":9454741141},{"date":"2022-04-22","current":99.794282,"twenty":-51.235376,"median":23.504791,"eighty":264.609771,"marketCap":8941567652},{"date":"2022-04-29","current":95.96752,"twenty":-50.869461,"median":23.733072,"eighty":264.609771,"marketCap":8598689764},{"date":"2022-05-06","current":106.411117,"twenty":-50.538701,"median":24.05378,"eighty":264.609771,"marketCap":7597753757},{"date":"2022-05-13","current":112.603765,"twenty":-50.513367,"median":24.270178,"eighty":264.609771,"marketCap":8039908807},{"date":"2022-05-20","current":115.361299,"twenty":-50.513367,"median":24.572517,"eighty":264.609771,"marketCap":8236796731},{"date":"2022-05-27","current":124.624471,"twenty":-50.513367,"median":24.659455,"eighty":264.609771,"marketCap":8898187232},{"date":"2022-06-03","current":127.890676,"twenty":-50.513367,"median":24.724335,"eighty":264.609771,"marketCap":9131394287},{"date":"2022-06-10","current":126.244188,"twenty":-50.513367,"median":24.885236,"eighty":264.609771,"marketCap":9013834993},{"date":"2022-06-17","current":124.865421,"twenty":-50.513367,"median":25.0449,"eighty":264.609771,"marketCap":8915391031},{"date":"2022-06-24","current":131.50492,"twenty":-50.518997,"median":25.258455,"eighty":264.839255,"marketCap":9389451274},{"date":"2022-07-01","current":132.856915,"twenty":-50.518997,"median":25.998572,"eighty":264.839255,"marketCap":9485983703},{"date":"2022-07-08","current":127.930835,"twenty":-50.518997,"median":26.276232,"eighty":264.839255,"marketCap":9134261587},{"date":"2022-07-15","current":127.395391,"twenty":-50.518997,"median":26.439753,"eighty":264.839255,"marketCap":9096030922},{"date":"2022-07-22","current":127.556024,"twenty":-50.518997,"median":26.634392,"eighty":264.839255,"marketCap":9107500121},{"date":"2022-07-29","current":126.003238,"twenty":-50.518997,"median":26.826436,"eighty":264.839255,"marketCap":8996631194},{"date":"2022-08-05","current":815.065239,"twenty":-50.518997,"median":26.995123,"eighty":267.473329,"marketCap":9943795914},{"date":"2022-08-12","current":828.064055,"twenty":-50.518997,"median":27.355854,"eighty":332.018448,"marketCap":10102381477},{"date":"2022-08-19","current":838.803881,"twenty":-50.518997,"median":43.704114,"eighty":339.430085,"marketCap":10233407347},{"date":"2022-08-26","current":822.106196,"twenty":-50.518997,"median":44.350706,"eighty":343.175456,"marketCap":10029695593},{"date":"2022-09-02","current":807.525119,"twenty":-50.518997,"median":44.8698,"eighty":348.23866,"marketCap":9851806456},{"date":"2022-09-09","current":834.962629,"twenty":-50.518997,"median":45.079259,"eighty":349.917301,"marketCap":10186544079},{"date":"2022-09-16","current":831.670128,"twenty":-50.518997,"median":45.502731,"eighty":362.813526,"marketCap":10146375564},{"date":"2022-09-23","current":811.366371,"twenty":-50.518997,"median":45.962631,"eighty":364.154541,"marketCap":9898669723},{"date":"2022-09-30","current":832.610843,"twenty":-50.518997,"median":46.285926,"eighty":365.308101,"marketCap":10157852283},{"date":"2022-10-07","current":848.602992,"twenty":-50.518997,"median":47.210279,"eighty":371.273896,"marketCap":10352956498},{"date":"2022-10-14","current":848.446206,"twenty":-50.518997,"median":49.327638,"eighty":378.797857,"marketCap":10351043711},{"date":"2022-10-21","current":869.690678,"twenty":-50.518997,"median":50.903135,"eighty":389.463975,"marketCap":10610226271},{"date":"2022-10-28","current":905.986584,"twenty":-50.518997,"median":51.513299,"eighty":431.928138,"marketCap":11053036327},{"date":"2022-11-04","current":201.221497,"twenty":-50.458475,"median":52.087035,"eighty":434.881702,"marketCap":11711091146},{"date":"2022-11-11","current":200.593816,"twenty":-50.126307,"median":52.792822,"eighty":434.881702,"marketCap":11674560078},{"date":"2022-11-18","current":198.47952,"twenty":-49.947556,"median":54.395533,"eighty":434.881702,"marketCap":11551508062},{"date":"2022-11-25","current":201.766589,"twenty":-49.629464,"median":57.560591,"eighty":434.881702,"marketCap":11742815494},{"date":"2022-12-02","current":209.463947,"twenty":-49.385812,"median":59.991394,"eighty":434.881702,"marketCap":12190801742},{"date":"2022-12-09","current":193.656283,"twenty":-48.929381,"median":62.264354,"eighty":434.881702,"marketCap":11270795649},{"date":"2022-12-16","current":193.573693,"twenty":-48.286719,"median":62.627396,"eighty":434.881702,"marketCap":11265988929},{"date":"2022-12-23","current":198.727289,"twenty":-40.846451,"median":63.253512,"eighty":434.881702,"marketCap":11565928220},{"date":"2022-12-30","current":197.290229,"twenty":-39.648276,"median":63.753352,"eighty":434.881702,"marketCap":11482291302},{"date":"2023-01-06","current":203.20365,"twenty":-39.648276,"median":64.910878,"eighty":434.881702,"marketCap":11826452411},{"date":"2023-01-13","current":180.028985,"twenty":-39.648276,"median":65.66327,"eighty":434.881702,"marketCap":10477686948},{"date":"2023-01-20","current":183.943736,"twenty":-39.648276,"median":66.031573,"eighty":434.881702,"marketCap":10705525447},{"date":"2023-01-27","current":178.806658,"twenty":-37.833689,"median":67.168053,"eighty":434.881702,"marketCap":10406547501},{"date":"2023-02-03","current":181.746851,"twenty":-35.951624,"median":67.783646,"eighty":434.881702,"marketCap":10577666711},{"date":"2023-02-10","current":64.510722,"twenty":15.966099,"median":67.783646,"eighty":434.881702,"marketCap":9966906536},{"date":"2023-02-17","current":64.729529,"twenty":16.188336,"median":67.783646,"eighty":434.881702,"marketCap":10000712304},{"date":"2023-02-24","current":64.0481,"twenty":16.573519,"median":67.783646,"eighty":434.881702,"marketCap":9895431481},{"date":"2023-03-03","current":63.254141,"twenty":16.938226,"median":67.783646,"eighty":434.881702,"marketCap":9772764834},{"date":"2023-03-10","current":59.897008,"twenty":17.137429,"median":67.783646,"eighty":434.881702,"marketCap":9254087752},{"date":"2023-03-17","current":58.921752,"twenty":17.302081,"median":67.783646,"eighty":434.881702,"marketCap":9103410611},{"date":"2023-03-24","current":60.672212,"twenty":17.624986,"median":67.783646,"eighty":434.881702,"marketCap":9373856762},{"date":"2023-03-31","current":63.279148,"twenty":17.970498,"median":67.68894,"eighty":434.086512,"marketCap":9776628351},{"date":"2023-04-06","current":63.898061,"twenty":18.054957,"median":67.68894,"eighty":434.086512,"marketCap":9872250383},{"date":"2023-04-14","current":64.873317,"twenty":18.158185,"median":67.783646,"eighty":434.881702,"marketCap":10022927524},{"date":"2023-04-21","current":65.367197,"twenty":18.484076,"median":67.783646,"eighty":434.881702,"marketCap":10099231974},{"date":"2023-04-28","current":63.70426,"twenty":18.731906,"median":67.783646,"eighty":434.881702,"marketCap":9842308130},{"date":"2023-05-05","current":146.11832,"twenty":19.078272,"median":68.588653,"eighty":434.881702,"marketCap":9351572473},{"date":"2023-05-12","current":149.137041,"twenty":19.909208,"median":69.22003,"eighty":434.881702,"marketCap":9544770653},{"date":"2023-05-19","current":144.639451,"twenty":20.507993,"median":87.443915,"eighty":434.881702,"marketCap":9256924881},{"date":"2023-05-26","current":140.538259,"twenty":21.155662,"median":90.238157,"eighty":434.881702,"marketCap":8994448566},{"date":"2023-06-02","current":139.028898,"twenty":21.398536,"median":90.937629,"eighty":434.881702,"marketCap":8897849477},{"date":"2023-06-09","current":143.358782,"twenty":21.506213,"median":91.668604,"eighty":434.881702,"marketCap":9174962017},{"date":"2023-06-16","current":147.658173,"twenty":21.60402,"median":92.617131,"eighty":434.881702,"marketCap":9450123060},{"date":"2023-06-23","current":149.18278,"twenty":21.770569,"median":93.488972,"eighty":435.676893,"marketCap":9547697898},{"date":"2023-06-30","current":144.060101,"twenty":21.895923,"median":94.02934,"eighty":436.472083,"marketCap":9219846442},{"date":"2023-07-07","current":143.922886,"twenty":21.989585,"median":94.91316,"eighty":436.472083,"marketCap":9211064707},{"date":"2023-07-14","current":146.407995,"twenty":22.061764,"median":95.529687,"eighty":436.472083,"marketCap":9370111693},{"date":"2023-07-21","current":149.274256,"twenty":22.130933,"median":95.839905,"eighty":436.472083,"marketCap":9553552388},{"date":"2023-07-28","current":154.366443,"twenty":22.209371,"median":96.635182,"eighty":436.472083,"marketCap":9879452347},{"date":"2023-08-04","current":57.179827,"twenty":22.369622,"median":96.794628,"eighty":436.472083,"marketCap":10086521560},{"date":"2023-08-11","current":57.938239,"twenty":22.419379,"median":96.794628,"eighty":436.472083,"marketCap":10220305417},{"date":"2023-08-18","current":57.738949,"twenty":22.500257,"median":96.794628,"eighty":436.472083,"marketCap":10185150535},{"date":"2023-08-25","current":59.27238,"twenty":22.577261,"median":96.794628,"eighty":436.472083,"marketCap":10455647821},{"date":"2023-09-01","current":60.279905,"twenty":22.655218,"median":96.794628,"eighty":436.472083,"marketCap":10633375280},{"date":"2023-09-08","current":60.052935,"twenty":22.776647,"median":96.794628,"eighty":436.472083,"marketCap":10593337776},{"date":"2023-09-15","current":62.986937,"twenty":22.862726,"median":96.982474,"eighty":437.267273,"marketCap":11110895761},{"date":"2023-09-22","current":62.616035,"twenty":22.973265,"median":96.982474,"eighty":437.267273,"marketCap":11045468619},{"date":"2023-09-29","current":63.750885,"twenty":23.123786,"median":96.982474,"eighty":437.267273,"marketCap":11245656142},{"date":"2023-10-06","current":63.828387,"twenty":23.187287,"median":96.982474,"eighty":437.267273,"marketCap":11259327485},{"date":"2023-10-13","current":61.580831,"twenty":23.281362,"median":96.982474,"eighty":437.267273,"marketCap":10862858538},{"date":"2023-10-20","current":61.519936,"twenty":23.429531,"median":96.982474,"eighty":437.267273,"marketCap":10852116768},{"date":"2023-10-27","current":59.742927,"twenty":23.646846,"median":97.20033,"eighty":438.237231,"marketCap":10538652404},{"date":"2023-11-03","current":58.32872,"twenty":23.985048,"median":97.20033,"eighty":438.237231,"marketCap":11140785548},{"date":"2023-11-10","current":57.690854,"twenty":23.985048,"median":95.96752,"eighty":392.709437,"marketCap":11018953164},{"date":"2023-11-17","current":55.952155,"twenty":23.985048,"median":95.589827,"eighty":383.351833,"marketCap":10686861664},{"date":"2023-11-24","current":57.701142,"twenty":23.985048,"median":95.489796,"eighty":377.211039,"marketCap":11020918202},{"date":"2023-12-01","current":59.974826,"twenty":23.985048,"median":94.859599,"eighty":367.477481,"marketCap":11455191702},{"date":"2023-12-08","current":61.728957,"twenty":24.007626,"median":93.696554,"eighty":365.084276,"marketCap":11790230760},{"date":"2023-12-15","current":62.423408,"twenty":24.007626,"median":93.180509,"eighty":363.965151,"marketCap":11922870856},{"date":"2023-12-22","current":62.32567,"twenty":24.007626,"median":91.967766,"eighty":361.900364,"marketCap":11904202990},{"date":"2023-12-29","current":67.979014,"twenty":23.985048,"median":91.60565,"eighty":350.289361,"marketCap":12983991624},{"date":"2024-01-05","current":68.714617,"twenty":23.96247,"median":91.018028,"eighty":348.300433,"marketCap":13124491874},{"date":"2024-01-12","current":67.171393,"twenty":23.96247,"median":90.125498,"eighty":344.013234,"marketCap":12829736105},{"date":"2024-01-19","current":70.34529,"twenty":23.939892,"median":87.443915,"eighty":339.611278,"marketCap":13435950470},{"date":"2024-01-26","current":72.536668,"twenty":23.96247,"median":71.993968,"eighty":332.715749,"marketCap":13854503662},{"date":"2024-02-02","current":73.277416,"twenty":23.96247,"median":71.906519,"eighty":313.773789,"marketCap":13995986431},{"date":"2024-02-09","current":52.891564,"twenty":23.96247,"median":70.886562,"eighty":261.06275,"marketCap":13207023489},{"date":"2024-02-16","current":53.400095,"twenty":23.96247,"median":69.696194,"eighty":257.160449,"marketCap":13334003660},{"date":"2024-02-23","current":53.149035,"twenty":23.96247,"median":68.840647,"eighty":255.027964,"marketCap":13271313941},{"date":"2024-03-01","current":51.965465,"twenty":23.985048,"median":68.588653,"eighty":248.779166,"marketCap":12975776696},{"date":"2024-03-08","current":53.930111,"twenty":23.985048,"median":68.148768,"eighty":244.412047,"marketCap":13466348621},{"date":"2024-03-15","current":55.456397,"twenty":23.985048,"median":67.762962,"eighty":240.453561,"marketCap":13847462308},{"date":"2024-03-22","current":57.281564,"twenty":23.985048,"median":67.173314,"eighty":238.312647,"marketCap":14303206612},{"date":"2024-03-28","current":54.926381,"twenty":23.985048,"median":66.336739,"eighty":235.829511,"marketCap":13715117346},{"date":"2024-04-05","current":54.838709,"twenty":23.96247,"median":65.960543,"eighty":230.641182,"marketCap":13693225698},{"date":"2024-04-12","current":54.753332,"twenty":23.96247,"median":65.52974,"eighty":224.225614,"marketCap":13671906957},{"date":"2024-04-19","current":53.387822,"twenty":23.96247,"median":65.224959,"eighty":214.926531,"marketCap":13330939072},{"date":"2024-04-26","current":55.490466,"twenty":23.985048,"median":65.016713,"eighty":211.299293,"marketCap":13855969266},{"date":"2024-05-03","current":38.063574,"twenty":24.176232,"median":64.926662,"eighty":209.711716,"marketCap":14072103451},{"date":"2024-05-10","current":38.017298,"twenty":24.502187,"median":64.926662,"eighty":209.711716,"marketCap":14054995122},{"date":"2024-05-17","current":38.629778,"twenty":24.632825,"median":64.926662,"eighty":209.711716,"marketCap":14281428883},{"date":"2024-05-24","current":38.248679,"twenty":24.716549,"median":64.926662,"eighty":209.711716,"marketCap":14140536765},{"date":"2024-05-31","current":37.200658,"twenty":24.820876,"median":64.926662,"eighty":209.711716,"marketCap":13753083441},{"date":"2024-06-07","current":36.223413,"twenty":24.997349,"median":64.926662,"eighty":209.711716,"marketCap":13391795796},{"date":"2024-06-14","current":37.091773,"twenty":25.132663,"median":64.971688,"eighty":209.794306,"marketCap":13712828551},{"date":"2024-06-21","current":36.495626,"twenty":25.611349,"median":65.016713,"eighty":209.876896,"marketCap":13492433023},{"date":"2024-06-28","current":36.560957,"twenty":26.148895,"median":65.029383,"eighty":211.299293,"marketCap":13516585958},{"date":"2024-07-05","current":37.628033,"twenty":26.322584,"median":65.029383,"eighty":211.299293,"marketCap":13911083888},{"date":"2024-07-12","current":39.879237,"twenty":26.601174,"median":65.029383,"eighty":211.299293,"marketCap":14743353755},{"date":"2024-07-15","current":40.131034,"twenty":26.615894,"median":65.029383,"eighty":211.299293,"marketCap":14836443190},{"date":"2024-08-02","current":45.591134,"twenty":26.86173,"median":65.123383,"eighty":209.546537,"marketCap":15464512534},{"date":"2024-08-09","current":43.679968,"twenty":26.86173,"median":64.926662,"eighty":203.758652,"marketCap":14816245015},{"date":"2024-08-16","current":43.989565,"twenty":26.86173,"median":64.824841,"eighty":201.969234,"marketCap":14921260314},{"date":"2024-08-23","current":45.418474,"twenty":26.86173,"median":64.529477,"eighty":201.100989,"marketCap":15405946309},{"date":"2024-08-30","current":38.232251,"twenty":26.86173,"median":64.341928,"eighty":199.724972,"marketCap":12968379659},{"date":"2024-09-06","current":36.082934,"twenty":26.86173,"median":64.216895,"eighty":198.7372,"marketCap":12239331141},{"date":"2024-09-13","current":36.103772,"twenty":26.86173,"median":63.998087,"eighty":198.373805,"marketCap":12246399478},{"date":"2024-09-20","current":35.859667,"twenty":26.86173,"median":63.828387,"eighty":196.979242,"marketCap":12163598954},{"date":"2024-09-27","current":34.511134,"twenty":26.86173,"median":63.679253,"eighty":196.20378,"marketCap":11706176546},{"date":"2024-10-04","current":33.305492,"twenty":26.86173,"median":63.327173,"eighty":193.88423,"marketCap":11297222738},{"date":"2024-10-11","current":33.463267,"twenty":26.86173,"median":63.274802,"eighty":189.672156,"marketCap":11350740150},{"date":"2024-10-18","current":35.264288,"twenty":26.86173,"median":63.195636,"eighty":182.652034,"marketCap":11961646456},{"date":"2024-10-25","current":34.389081,"twenty":26.86173,"median":62.986937,"eighty":181.026669,"marketCap":11664776284},{"date":"2024-10-31","current":32.619923,"twenty":26.86173,"median":62.892828,"eighty":179.513625,"marketCap":12588028444},{"date":"2024-11-08","current":32.528095,"twenty":26.852907,"median":62.621935,"eighty":178.558889,"marketCap":12552592025},{"date":"2024-11-15","current":32.238181,"twenty":26.852907,"median":62.553735,"eighty":154.18349,"marketCap":12440714189},{"date":"2024-11-22","current":32.795708,"twenty":26.852907,"median":62.388604,"eighty":149.95728,"marketCap":12655863875},{"date":"2024-11-29","current":33.254848,"twenty":26.852907,"median":62.257511,"eighty":149.213272,"marketCap":12833045969},{"date":"2024-12-06","current":33.168268,"twenty":26.852907,"median":61.886863,"eighty":148.618675,"marketCap":12799634488},{"date":"2024-12-13","current":33.265343,"twenty":26.852907,"median":61.550384,"eighty":147.743551,"marketCap":12837095845},{"date":"2024-12-20","current":35.40887,"twenty":26.852907,"median":61.259752,"eighty":146.444586,"marketCap":13664283108},{"date":"2024-12-27","current":36.476699,"twenty":26.852907,"median":61.063228,"eighty":145.764611,"marketCap":14076358036},{"date":"2025-01-03","current":36.169731,"twenty":26.852907,"median":60.907571,"eighty":144.785813,"marketCap":13957899150},{"date":"2025-01-10","current":36.392742,"twenty":26.844083,"median":60.680648,"eighty":144.044855,"marketCap":14043959024},{"date":"2025-01-17","current":37.234935,"twenty":26.844083,"median":60.329767,"eighty":143.386225,"marketCap":14368961609},{"date":"2025-01-24","current":38.719925,"twenty":26.844083,"median":60.247462,"eighty":142.678807,"marketCap":14942019125},{"date":"2025-01-31","current":40.218033,"twenty":26.844083,"median":59.974826,"eighty":141.016986,"marketCap":15520138987},{"date":"2025-02-07","current":44.648909,"twenty":26.844083,"median":59.754628,"eighty":137.028614,"marketCap":15238672574},{"date":"2025-02-14","current":34.141082,"twenty":26.844083,"median":59.521493,"eighty":131.55311,"marketCap":11652351200},{"date":"2025-02-21","current":33.919064,"twenty":26.844083,"median":59.27238,"eighty":130.444741,"marketCap":11576576519},{"date":"2025-02-28","current":34.328044,"twenty":26.844083,"median":59.040533,"eighty":129.095424,"marketCap":11716161457},{"date":"2025-03-07","current":32.91122,"twenty":26.83526,"median":58.73161,"eighty":127.751461,"marketCap":11232599351},{"date":"2025-03-14","current":31.839108,"twenty":26.83526,"median":58.3673,"eighty":127.30972,"marketCap":10866687407},{"date":"2025-03-21","current":32.154607,"twenty":26.83526,"median":57.889136,"eighty":126.142453,"marketCap":10974367216},{"date":"2025-03-28","current":33.302672,"twenty":26.83526,"median":57.695998,"eighty":125.695358,"marketCap":11366202078},{"date":"2025-04-04","current":30.054201,"twenty":26.83526,"median":57.273606,"eighty":124.678015,"marketCap":10257498857},{"date":"2025-04-11","current":26.501916,"twenty":26.750137,"median":56.720224,"eighty":122.876248,"marketCap":9045103969},{"date":"2025-04-17","current":29.242083,"twenty":26.695569,"median":56.384258,"eighty":119.27935,"marketCap":9980323052},{"date":"2025-04-25","current":30.658387,"twenty":26.680493,"median":56.257145,"eighty":115.693273,"marketCap":10463707627},{"date":"2025-05-02","current":30.898993,"twenty":26.680493,"median":56.044889,"eighty":114.003704,"marketCap":10545826362},{"date":"2025-05-09","current":38.032908,"twenty":26.680493,"median":55.948895,"eighty":113.591967,"marketCap":11630463166},{"date":"2025-05-16","current":38.922888,"twenty":26.680493,"median":55.567979,"eighty":113.591967,"marketCap":11902619171},{"date":"2025-05-23","current":38.550714,"twenty":26.680493,"median":55.400605,"eighty":113.591967,"marketCap":11788808478},{"date":"2025-05-30","current":40.019991,"twenty":26.680493,"median":55.045675,"eighty":113.591967,"marketCap":12238113301},{"date":"2025-06-06","current":40.327439,"twenty":26.680493,"median":54.834724,"eighty":113.591967,"marketCap":12332130830},{"date":"2025-06-13","current":40.456891,"twenty":26.680493,"median":54.478076,"eighty":113.591967,"marketCap":12371717158},{"date":"2025-06-18","current":40.414819,"twenty":26.680493,"median":54.092022,"eighty":113.591967,"marketCap":12358851601}],"updateTime":1750458813782}}}